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ORIGINAL PAPER
ALS mutant SOD1 interacts with G3BP1 and affects stress 
granule dynamics
Jozsef Gal1 · Lisha Kuang1 · Kelly R. Barnett1 · Brian Z. Zhu1,2 · 
Susannah C. Shissler1 · Konstantin V. Korotkov1 · Lawrence J. Hayward3 · 
Edward J. Kasarskis4 · Haining Zhu1,5  
Received: 6 February 2016 / Revised: 24 July 2016 / Accepted: 25 July 2016 / Published online: 1 August 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
patient carrying SOD1 mutation L144F. Mutant SOD1, 
unlike wild-type SOD1, interacted with G3BP1 in an RNA-
independent manner. Moreover, the interaction is specific 
for G3BP1 since mutant SOD1 showed little interaction 
with four other RNA-binding proteins implicated in ALS. 
The RNA-binding RRM domain of G3BP1 and two par-
ticular phenylalanine residues (F380 and F382) are critical 
for this interaction. Mutant SOD1 delayed the formation 
of G3BP1- and TIA1-positive stress granules in response 
to hyperosmolar shock and arsenite treatment in N2A cells. 
In summary, the aberrant mutant SOD1–G3BP1 interaction 
affects stress granule dynamics, suggesting a potential link 
between pathogenic SOD1 mutations and RNA metabolism 
alterations in ALS.
Keywords ALS · SOD1 · G3BP1 · Stress granules · 
Neurodegeneration
Introduction
Amyotrophic lateral sclerosis (ALS or Lou Gehrig’s dis-
ease) is a progressive neurodegenerative disease with no 
cure available [37, 49, 71]. A better understanding of the 
molecular etiology of the disease is needed to develop 
effective preventive measures or cures. Approximately 
10–15 % of ALS cases are familial and studies of the ALS 
genes whose mutations cause familial ALS have provided 
valuable insights into the disease mechanism. The first 
identified ALS gene encodes copper/zinc superoxide dis-
mutase (SOD1) [14, 51]. The ALS mutations in SOD1 
cause toxicity that is foreign to the wild-type (WT) pro-
tein (termed as “gain-of-function”) [9], but the nature of 
such toxicity is still not fully understood. Mutations in a 
group of genes involved in RNA metabolism have been 
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal 
neurodegenerative disease. Mutations in Cu/Zn superoxide 
dismutase (SOD1) are responsible for approximately 20 % 
of the familial ALS cases. ALS-causing SOD1 mutants 
display a gain-of-toxicity phenotype, but the nature of this 
toxicity is still not fully understood. The Ras GTPase-acti-
vating protein-binding protein G3BP1 plays a critical role 
in stress granule dynamics. Alterations in the dynamics of 
stress granules have been reported in several other forms of 
ALS unrelated to SOD1. To our surprise, the mutant G93A 
SOD1 transgenic mice exhibited pathological cytoplasmic 
inclusions that co-localized with G3BP1-positive gran-
ules in spinal cord motor neurons. The co-localization was 
also observed in fibroblast cells derived from familial ALS 
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found in recent years, including TDP-43 [45], FUS [35, 
67], ataxin-2 [19], hnRNPA1 [33] and Matrin-3 [29]. The 
seemingly unrelated pathogenic mechanisms elicited by 
the mutations in SOD1 and in RNA metabolism regulators 
have not been reconciled yet.
The Ras GTPase-activating protein-binding protein 
G3BP1 [48] is an important regulator of RNA metabo-
lism [5, 24, 66], translation [1, 47] and stress granule (SG) 
dynamics [2, 65, 70]. G3BP1 was reported to play a critical 
role in the secondary aggregation step of SG formation [2], 
and has been used as a reliable marker of SGs [31]. The 
misregulation of SG dynamics has been reported in many 
forms of ALS [36]. G3BP1 is critical for neuronal survival 
since G3BP1 null mice demonstrate widespread neuronal 
cell death in the central nervous system [73]. G3BP1 is 
also critical for synaptic plasticity and calcium homeostasis 
[43].
In this study, we initially tested whether aggregated 
ALS mutant SOD1-containing inclusions were in any way 
related to G3BP1-positive stress granules. Interestingly, 
mutant SOD1 inclusions were co-localized with G3BP1-
positive granules in spinal cord motor neurons of G93A 
SOD1 transgenic mice as well as in cultured cells. ALS-
related mutants of SOD1, unlike wild-type SOD1, inter-
acted with G3BP1 and the interaction was preserved in 
the presence of RNase, suggesting a direct protein–protein 
interaction. Domain deletion mutations, molecular mod-
eling and point mutagenesis showed that the RNA-binding 
RRM domain of G3BP1 interacted with mutant SOD1 
via residues critical to the RNA binding. Furthermore, the 
expression of mutant SOD1 perturbed SG dynamics and 
resulted in a delayed formation of SG in response to hyper-
osmolar stress and arsenite treatment. Our results suggest 
that G3BP1 represents a potential link between pathogenic 
SOD1 mutations and RNA metabolism alterations in ALS.
Materials and methods
Plasmids
The WT and A4V mutant SOD1-EGFP [74], SOD1-3xHA 
[21], 3xFLAG-FUS [22], FLAG-TDP-43 (a gift from Dr. 
Francisco Baralle) [3], FLAG-MATR3 (a gift from Dr. 
Yossi Shiloh, Addgene plasmid # 32880) [52], and FLAG-
hnRNPA1 (a gift from Dr. J. Paul Taylor) [33] expression 
constructs were previously reported. The human G3BP1 
expression constructs used in this study were based on 
the FLAG-G3BP1 plasmid [34], a generous gift from Dr. 
Zhi-Min Yuan (University of Texas Health Science Center 
at San Antonio). The 3xFLAG-tagged G3BP1 constructs 
were generated from p3xFLAG-CMV10 (Sigma) using 
standard cloning techniques. The F380L/F382L G3BP1 
mutation and the W32S SOD1 mutation were introduced 
with the QuikChange II Site-Directed Mutagenesis Kit 
(Agilent). The A4V/W32S double mutant SOD1-EGFP 
and the EGFP-G3BP1 expression constructs were gener-
ated by subcloning the respective fragments to pEGFP-N3 
and pEGFP-C3 (Clontech), respectively. The mCherry-WT 
and F380L/F382L double mutant G3BP1 constructs were 
made by subcloning the respective G3BP1 fragments to 
pmCherry-C1 (Clontech). All plasmid constructs were veri-
fied with sequencing.
Cell culture and transfection
N2A and HEK293T (293T) cells were cultured in DMEM 
(Sigma, D5796) supplemented with 10 % fetal bovine 
serum and penicillin–streptomycin at 37 °C in 5 % 
CO2/95 % air with humidification. N2A and 293T cells 
were transfected with Lipofectamine 2000 (Life Technolo-
gies) and Polyethylenimine “Max” (Polysciences, Inc.), 
respectively. The G3BP1-null 293T cells were generated 
by employing CRISPR technology (G3BP1 Double Nick-
ase Plasmids, Santa Cruz, sc-400745-NIC) following the 
manufacturer’s protocol.
Animals
Transgenic mouse strains B6.Cg-Tg(SOD1)2Gur/J and 
B6.Cg-Tg(SOD1-G93A)1Gur/J [26] were bred and main-
tained as hemizygotes at the University of Kentucky ani-
mal facility. Transgenic mice were identified using PCR. 
The mice were killed at age 60, 90 and 125 ± 5 days. 
Mice were anesthetized with an intraperitoneal injection 
of 0.1 ml Pentobarbital (50 mg/ml, Abbott Laboratories) 
and transcardially perfused with 0.1 M phosphate buffered 
saline (PBS), pH 7.5 before spinal cords were dissected. 
All animal procedures were approved by the university 
IACUC committee.
Clinical materials
Human skin fibroblast cell cultures were established as pre-
viously described [16]. Briefly, punch skin biopsy (3 mm) 
was obtained after informed consent from a 63-year-old 
male with symptomatic ALS with a documented L144F 
SOD1 mutation (Athena Diagnostics). The control skin 
biopsy was obtained from a 64-year-old healthy male who 
was free of neurological disease or any known ALS gene 
mutation. Skin biopsies were washed with PBS and cut into 
small pieces. Fibroblast growth medium [MEM (Sigma, 
M5650) supplemented with 20 % FBS, 2 mM l-glu-
tamine, 100 unit/ml penicillin, and 100 µg/ml streptomy-
cin] was added to the minced biopsy tissue and transferred 
along with tissue fragments into tissue culture plates. 
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Cultures were maintained in a humidified atmosphere of 
5 % CO2/95 % air at 37 °C to allow fibroblast cells grow 
from tissue fragments. Fibroblast cells were then main-
tained under the same conditions as above. The study was 
approved by the Institutional Review Board of the Univer-
sity of Kentucky.
Fluorescence microscopy
N2A or 293T cells were seeded on gelatin-treated glass 
coverslips and transfected with SOD1-EGFP constructs. 
Twenty-four hours later, cells were rinsed with 1× PBS, 
fixed with 4 % formaldehyde in 1× PBS, and permeabi-
lized with 1× PBS supplemented with 0.25 % Triton-
X100. Primary fibroblast cells were cultured, fixed and 
permeabilized similarly as above. Mouse spinal cords were 
dissected, post-fixed in 4 % formaldehyde in 1× PBS for 
3 h, cryopreserved in 30 % sucrose overnight, embedded in 
Tissue-Tek OCT compound (Sakura). Sections were cut at 
12 μm and permeabilized with 1× PBS supplemented with 
0.1 % Triton-X100. The primary antibodies were sheep 
anti-human SOD1 (The Binding Site, PC077), mouse anti-
G3BP1 (BD Biosciences, 611126), rabbit anti-G3BP1 
(Proteintech, 13057-2-AP), goat anti-TIA1 (Santa Cruz, 
sc-1751), mouse anti-eIF3 p110 (Santa Cruz, sc-74507) 
and mouse anti-GE-1/p70 S6 kinase alpha (Santa Cruz, 
sc-8418). The secondary antibodies were Alexa Fluor 488 
donkey anti-sheep (Life Technologies, A11015), Alexa 
Fluor 568 donkey anti-mouse (Life Technologies, A10037), 
Alexa Fluor 647 donkey anti-mouse (Life Technologies, 
A-31571), Alexa Fluor 568 donkey anti-rabbit (Life Tech-
nologies, A-10042), Alexa Fluor 647 donkey anti-rabbit 
(Life Technologies, A-31573), and Alexa Fluor 568 don-
key anti-goat (Life Technologies, A-11057). The samples 
were mounted by applying Vectashield Mounting Medium 
(Vector Laboratories) and visualized using a Nikon A1 or a 
Leica SP5 confocal microscope with a 60× objective.
Co‑immunoprecipitation assays
The lysates were prepared in 1× RIPA buffer (Millipore) 
supplemented with protease inhibitor cocktail (Sigma, 
P-8340, 1:500) and 1 mM sodium orthovanadate. Mouse 
spinal cord extracts were prepared using a dounce homog-
enizer. Transfected cell lysates were homogenized by pass-
ing through a 23-gauge needle several times. Immunopre-
cipitations were performed at 4 °C for 2 h. The endogenous 
G3BP1 immunoprecipitations were done from spinal cord 
extracts with rabbit anti-G3BP1 Antibody (Millipore, 
07-1801) and Protein A UltraLink Resin (Thermo Scien-
tific Pierce, 53139). The FLAG immunoprecipitations were 
performed using EZview Red Anti-FLAG M2 Affinity Gel 
(Sigma, F2426) and the bound proteins were eluted with 
3xFLAG peptide (Sigma, F4799). Where indicated, RNase 
Cocktail (Ambion Life Technologies, AM2286) was added 
to the immunoprecipitation mixtures at 1:100 dilution.
The in vitro SOD1–G3BP1 binding assays were per-
formed using 2 μg WT or G93A mutant human SOD1 
purified from insect cells as described [27] and 1.5 μg of 
6xHis-tagged human G3BP1 purified from E. coli (Fitzger-
ald Industries, 80R-1601) in 500 μl 1× RIPA buffer. The 
mixtures were incubated at 37 °C for 2 h, cooled to 4 °C 
and G3BP1 was immunoprecipitated with mouse anti-
G3BP1 (Millipore, 05-1938) and Protein G UltraLink 
Resin (Thermo Scientific Pierce, 53126).
Western blotting
The nitrocellulose membranes were blocked and antibodies 
were applied in 5 % milk in TBST (100 mM TRIS–HCl, 
pH7.5, 0.9 % NaCl, 0.1 % Tween-20). The antibodies used 
were rabbit anti-G3BP1 (Millipore, 07-1801), rabbit anti-
SOD1 (Santa Cruz, sc-11407), mouse anti-FLAG M2-HRP 
(Sigma, A8592), rabbit anti-HA (Santa Cruz, sc-805), 
mouse anti-PABP1 (Santa Cruz, sc-32318) and goat anti-
actin (Santa Cruz, sc-1616). All immunoblotting images 
were acquired using a BioRad ChemiDoc MP system.
In silico docking
The homology model of the RRM domain of G3BP1 was 
obtained using a leading homology modeling server Raptor 
X [30]. The model was docked to the SOD1 A4V mutant 
dimer (PDB ID: 3GZQ, [23]) using the protein–protein 
interaction modeling server HADDOCK [17]. The dock-
ing model was further refined using Rosetta Docking [12] 
as implemented in the ROSIE server [40], which evaluates 
protein–protein complexes by using rigid body perturba-
tions of the protein chains.
Stress granule induction and analysis
N2A cells grown on gelatin-treated glass coverslips were 
transfected with WT or A4V mutant SOD1–EGFP con-
structs. Twenty-four hours later, the cells were treated 
with 0.5 M d-sorbitol (Sigma, S1876) or 0.5 mM sodium 
arsenite dissolved in fresh medium for the indicated times 
at 37 °C to induce stress granules, with or without recov-
ery in fresh medium as indicated. Control cells were treated 
with fresh medium without sorbitol or arsenite. The cells 
were fixed and G3BP1 immunofluorescence experiments 
were performed as above. Z-stack images of random view-
fields were acquired with identical imaging parameters. 
Maximum intensity projections of the Z-stacks were ana-
lyzed for stress granule formation as published [10] using 
ImageJ (http://imagej.nih.gov/ij). ANOVA with post hoc 
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Tukey HSD (honest significant difference) test was used 
to determine p values for multiple pair-wise comparisons. 
Student’s t test (two-tailed distribution, two-sample une-
qual variance) was used to determine p values for simple 
pair-wise comparison.
Results
Mutant SOD1 inclusions are co‑localized with stress 
granule markers in ALS model systems
We set forth to determine whether there is a correlation 
between G3BP1-positive stress granules and mutant SOD1 
inclusions in murine and cellular ALS model systems. 
Interestingly, we found that mutant SOD1 inclusions gen-
erally co-localized with G3BP1 in spinal cord motor neu-
rons from 90-day-old symptomatic G93A mutant SOD1 
transgenic mice (Fig. 1a). In contrast, no obvious G3BP1 
or SOD1 inclusions were observed in age- and gender-
matched WT SOD1 transgenic mice. The G93A SOD1 
inclusions also co-localized with an additional stress gran-
ule marker, TIA1 [31] (Fig. 1a). The co-localization of all 
three proteins, G93A SOD1, TIA1 and G3BP1 was also 
demonstrated (Supplemental Fig. 1). No fluorescence sig-
nals were observed in primary antibody-omitted samples 
(Supplemental Fig. 2). Examination of three pairs of WT 
and G93A SOD1 mice showed that 49 % spinal cord motor 
neurons in 90-day-old G93A mice contained SOD1 inclu-
sions and nearly all motor neurons with SOD1 inclusions 
also contained G3BP1 co-inclusions (Fig. 1b). In contrast, 
less than 3 % motor neurons in WT SOD mice showed 
SOD1 inclusions and no WT SOD1–G3BP1 co-inclusions 
were observed.
In addition, the co-localization of G3BP1 with SOD1 
inclusions was observed in human fibroblasts derived 
from an ALS patient carrying the L144F SOD1 mutation 
(Fig. 1c). The SOD1 inclusions were also co-localized with 
TIA1 in L144F SOD1 ALS patient fibroblast cells (Fig. 1c, 
Supplemental Fig. 3). In contrast, no SOD1 inclusions 
were observed in fibroblast cells derived from an age- and 
gender-matched control (Fig. 1c, Supplemental Fig. 3).
In N2A cells transfected with A4V mutant SOD1, the 
G3BP1-positive mutant SOD1 inclusions were mostly 
round shaped with approximately 1–3 μm diameter 
(Fig. 1d). Quantification of 20 randomly selected view-
fields from three independent experiments showed that 
approximately 22 % of transfected cells contained mutant 
SOD1 inclusions, and 97 % of N2A cells with mutant 
SOD1 inclusions also showed G3BP1 co-inclusions 
(Fig. 1d). Approximately 4 % of N2A cells expressing 
WT SOD1 contained inclusions and no G3BP1 co-inclu-
sions were observed. The mutant SOD1 inclusions also 
co-localized with TIA1 (Fig. 1d) and another SG marker 
eIF3 [31] (Supplemental Fig. 4) in N2A cells. Similar co-
localization of mutant SOD1 inclusions and G3BP1 was 
observed in transfected 293T cells (Supplemental Fig. 5).
Processing bodies (P-bodies) are discrete cytoplasmic 
foci where mRNA degradation takes place [55] and are 
often intimately juxtaposed to stress granules [32]. We 
found that mutant SOD1 inclusions in N2A and 293T cells 
did not stain positive for the P-bodies marker GE-1 [31, 
57], but were in close proximity to GE-1 positive P-bod-
ies instead (Fig. 1f). The results collectively suggest that 
mutant SOD1 inclusions, which are positive for multiple 
stress granule markers, are likely stress granules.
ALS mutants of SOD1 interact with G3BP1
G3BP1 immunoprecipitation was performed with spi-
nal cord extracts from 60-, 90- and 125-day-old WT or 
G93A mutant SOD1 transgenic mice. A small amount of 
WT SOD1 was co-precipitated with G3BP1 while a sig-
nificantly higher amount of G93A mutant SOD1 was co-
precipitated with G3BP1 (Fig. 2a). We next tested whether 
G3BP1 can interact with other ALS-related SOD1 mutants. 
Cells were co-transfected with 3xHA-tagged WT or A4V, 
G85R or G93A mutant SOD1 and FLAG-tagged G3BP1 or 
FLAG vector control. FLAG immunoprecipitation showed 
Fig. 1  G3BP1 co-localizes with ALS mutant SOD1 inclusions. a 
Immunofluorescence of SOD1, G3BP1 and TIA1 in the spinal cord 
of 90-day-old G93A and WT SOD1 transgenic mice. Top G3BP1 and 
G93A mutant SOD1 are co-localized in inclusions in motor neurons 
(illustrated by arrows) while WT SOD1 shows even cytoplasmic dis-
tribution. Bottom TIA1 and G93A mutant SOD1 are co-localized in 
inclusions in motor neurons (illustrated by arrows). b Quantification 
of G93A SOD1 inclusions and the co-localization of G93A SOD1 
and G3BP1 in mouse spinal motor neurons. Three pairs of WT and 
G93A mice were examined and a total of over 200 motor neurons 
were counted. c Immunofluorescence of SOD1, G3BP1 and TIA1 
in human fibroblasts harboring the L144F ALS mutation in SOD1 
and in control fibroblasts. Top G3BP1 and SOD1 are co-localized in 
inclusions in the L144F SOD1 ALS patient-derived cells (illustrated 
by arrows), whereas WT SOD1 shows even cytoplasmic distribution 
in the control cells. Bottom TIA1 and L144F mutant SOD1 are co-
localized in inclusions as illustrated by the arrow. d Confocal micro-
scopic images of G3BP1, TIA1 and SOD1 in N2A cells express-
ing A4V mutant (top) or WT (bottom) SOD1. A4V mutant SOD1, 
G3BP1 and TIA1 are co-localized in inclusions with the size of 
approximately 1–3 µm, whereas WT SOD1 shows even cytoplasmic 
distribution. e Quantification of A4V SOD1 inclusions and the co-
localization of A4V SOD1 and G3BP1 in N2A cells. Three independ-
ent experiments were performed and at least five random viewfields 
from each experiment were included in the quantification. f Confo-
cal microscopic images of A4V mutant SOD1 and the P-body marker 
GE-1 in N2A (top) and 293T (bottom) cells. Mutant SOD1 inclusions 
and P-bodies are illustrated by arrows and zoom-in images show 
that they are localized in close proximity to each other. The confocal 
microscopic images were acquired with a Nikon A1 microscope. The 
nuclei were stained with DAPI. Scale bars 10 μm
▸
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that A4V, G85R and G93A mutant SOD1 all co-precipi-
tated with FLAG-G3BP1 (Fig. 2b, lanes 7–9) while no co-
precipitation of WT SOD1 was detected (lane 6). As nega-
tive controls, no WT or mutant SOD1 was co-precipitated 
with the FLAG vector (Fig. 2b, lanes 1–5).
ALS mutant SOD1 directly interacts with G3BP1
Since G3BP1 is an RNA-binding protein, we tested 
whether the mutant SOD1–G3BP1 interaction was depend-
ent on RNA. RNase was either included or omitted in the 
568 Acta Neuropathol (2016) 132:563–576
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immunoprecipitation mixture and the FLAG-G3BP1 co-
immunoprecipitation experiment was subsequently per-
formed. Mutant SOD1 was still co-precipitated by G3BP1 
in the presence of RNase (Fig. 2c, lanes 5, 6). The poly 
A-binding protein PABP1 was included as a control of the 
RNase treatment since G3BP1 was reported to interact with 
PABP1 in an RNA-dependent manner [44, 58]. The inter-
action of G3BP1 with the endogenous PABP1 was com-
pletely abolished in the presence of RNase (Fig. 2c, lanes 
5, 6). These results support that the G3BP1–mutant SOD1 
interaction was RNA-independent.
We next tested whether the G3BP1–mutant SOD1 inter-
action was direct. Purified WT or G93A mutant SOD1 and 
purified G3BP1 were used for immunoprecipitation. G93A 
SOD1, unlike WT SOD1, efficiently co-precipitated with 
G3BP1 (Fig. 2d, lane 2 versus lane 4), showing that mutant 
SOD1 and G3BP1 interact directly.
The specificity of the mutant SOD1–G3BP1 interaction
We next tested whether mutant SOD1 interacts with other 
RRM domain-containing RNA-binding proteins or specifi-
cally with G3BP1. The RNA-binding proteins implicated in 
ALS, hnRNPA1, FUS, TDP-43 and Matrin-3 were exam-
ined. Cells were co-transfected with WT or A4V mutant 
SOD1 along with FLAG-tagged G3BP1, hnRNPA1, FUS, 
TDP-43 or Matrin-3. FLAG immunoprecipitation was per-
formed and A4V mutant SOD1 only co-precipitated with 
G3BP1 (Fig. 3, lane 4), but not with any of the other four 
FLAG-tagged RNA-binding proteins (hnRNPA1, FUS, 
TDP-43 and Matrin-3).
Fig. 2  ALS mutants of SOD1 interact with G3BP1. a Endogenous 
G3BP1 was immunoprecipitated from 60, 90 or 125-day-old WT or 
G93A human SOD1 transgenic mouse spinal cord extracts. A sig-
nificantly higher amount of G93A SOD1 was co-precipitated with 
G3BP1 than WT SOD1 was. b FLAG-G3BP1 was immunoprecipi-
tated from cellular extracts of 293T cells transfected with the indi-
cated expression constructs. Multiple ALS-causing mutants were co-
precipitated with G3BP1. c FLAG-G3BP1 was immunoprecipitated 
from cellular extracts of 293T cells transfected with the indicated 
expression constructs, with or without the inclusion of RNase in the 
immunoprecipitation, as indicated. d G3BP1 purified from E. coli 
and WT or G93A mutant SOD1 purified from insect cells were com-
bined in vitro, followed by G3BP1 immunoprecipitation. The immu-
noprecipitations were followed by western blotting with the indicated 
antibodies. The positions and sizes of the closest molecular weight 
marker bands are shown. IB immunoblot, IP immunoprecipitation, 
Ext whole cell extracts (a–c) or pre-IP mixture (d)
Fig. 3  Mutant SOD1 selectively interacts with G3BP1. FLAG-
tagged G3BP1 (GBP), hnRNPA1 (hA1), FUS, TDP-43 (TDP) or 
Matrin-3 (MAT) was co-transfected with HA-tagged WT or A4V 
SOD1. FLAG immunoprecipitations were performed and followed by 
western blotting with the indicated antibodies. A4V SOD1 was only 
co-precipitated with G3BP1 but not other RNA-binding proteins. IB 
immunoblot, IP immunoprecipitation, Ext whole cell extracts
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Mutant SOD1 interacts with the RRM domain 
of G3BP1 via residues critical to RNA binding
G3BP1 is a multi-domain protein consisting of an NTF2 
oligomerization domain, a glutamic acid-rich domain, a 
PxxP domain and an RNA-binding RRM domain [65] 
(Fig. 4a). To determine which domain is responsible for 
the binding of mutant SOD1, we generated G3BP1 domain 
truncation mutants and tested their ability to co-precipitate 
A4V SOD1. Removing the RRM domain abolished the 
co-precipitation of A4V mutant SOD1 (Fig. 4b, lane 4), 
whereas truncation of the NTF2 domain did not impair 
A4V SOD1 binding (lane 5). In addition, the PxxP-RRM 
domain fragment co-precipitated with A4V mutant SOD1 
(lane 8), whereas the NTF2-Glu-rich domain fragment 
(lane 6) or the Glu-rich domain–PxxP domain fragment 
(lane 7) did not co-precipitate with mutant SOD1. Further-
more, the RRM domain alone also co-precipitated with 
A4V SOD1 (Fig. 4c). Thus, the RRM domain of G3BP1 is 
necessary and sufficient for mutant SOD1 binding.
The ALS-related mutants of SOD1 were reported to 
display higher hydrophobicity than WT SOD1 [64]. We 
hypothesized that a hydrophobic gain-of-interaction might 
be responsible for the mutant SOD1–G3BP1 interaction. 
In the lack of an experimentally determined structure of 
G3BP1, a homology model of the RRM domain of G3BP1 
was obtained with a p value 4.0 × 10−6 based on Bruno 
protein RRM domain (PDB ID: 2KHC) as the template 
using a leading homology modeling server Raptor X [30]. 
We next performed in silico docking of the G3BP1 RRM 
homology model with the crystal structure of A4V mutant 
SOD1 (PDB ID: 3GZQ, [23]) using the HADDOCK pro-
tein–protein interaction modeling server [17]. The dock-
ing model was further refined using the Rosetta Docking 
algorithm [12] that evaluates protein–protein complexes 
by using rigid body perturbations of the protein chains. 
Fig. 4  The binding of mutant SOD1 is mediated by the RRM 
domain of G3BP1. a The schematic domain structure of G3BP1. b 
The RRM domain of G3BP1 is necessary for the binding of mutant 
SOD1. A series of domain deletion mutants of G3BP1 were tested in 
FLAG-G3BP1 immunoprecipitations. c The isolated RRM domain of 
G3BP1 is sufficient for binding to mutant SOD1. FLAG immunopre-
cipitations were performed on cellular extracts with the expression 
of indicated constructs. d In silico docking of A4V mutant SOD1 
(green) and the RRM domain of G3BP1 (purple). The F380 and F382 
residues of G3BP1 and W32 of SOD1 are shown in stick representa-
tion. e The F380 and F382 residues of G3BP1 and the W32 residue 
of mutant SOD1 are important for the mutant SOD1–G3BP1 interac-
tion. FLAG immunoprecipitations were performed followed by west-
ern blotting with the indicated antibodies. 2FL F380L/F382L double 
G3BP1 mutant, 4V32S A4V/W32S double SOD1 mutant, IB immu-
noblot, IP immunoprecipitation, Ext whole cell extracts
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The docking model with the minimal energy is shown in 
Fig. 4d. The model positioned the RRM domain of G3BP1 
above the crevice between two monomers of SOD1. Inter-
estingly, the F380 and F382 residues of G3BP1 RRM and 
the W32 residue of SOD1 are located in close proximity 
(Fig. 4d), suggesting that these residues are critical to the 
interaction.
We generated the F380L/F382L double mutation (2FL), 
which caused a significant loss of interaction with mutant 
SOD1 (Fig. 4e, lane 6 compared to lane 5). In addition, we 
introduced a W32S mutation into A4V SOD1 and found 
that the co-precipitation of the A4V/W32S mutant with 
G3BP1 was impaired as compared to the A4V mutant 
(lane 5 versus lane 7). The interaction between A4V/W32S 
SOD1 and F380L/F382L G3BP1 was barely detectable 
(lane 8) as compared to the interaction between A4V SOD1 
and wild-type G3BP1 (lane 5). Therefore, the F380 and 
F382 residues in the RRM domain of G3BP1 and the W32 
residue of SOD1 directly participate in the mutant SOD1–
G3BP1 interaction.
The mutant SOD1–G3BP1 interaction is critical to the 
co‑localized inclusions
We tested the significance of mutant SOD1–G3BP1 inter-
action in the formation of protein inclusions by mutating 
the W32 residue in SOD1 and the F380 and F382 residues 
in G3BP1. G3BP1-null 293T cells were transfected with 
combinations of EGFP-tagged A4V or A4V/W32S double 
mutant SOD1 and mCherry-tagged WT or F380L/F382L 
double mutant G3BP1 (Fig. 5a). The number of transfected 
cells with green, red and co-localized green/red inclusions 
was counted from more than 150 cells in ten random view-
fields. The percentage of co-localized green/red inclusions 
out of the total number of green inclusions in the above 
groups of cells is shown in Fig. 5b. Whereas A4V SOD1 
co-localized with WT G3BP1 in 86.6 % of cells with SOD1 
inclusions, the F380L/F382L G3BP1 mutation signifi-
cantly decreased the co-localization to 36.1 % (p = 0.001), 
and the W32S SOD1 mutation to 49.1 % (p = 0.001). 
The combination of the W32S SOD1 mutation and the 
F380L/F382L G3BP1 mutation resulted in only 14.7 % 
of cells with SOD1 inclusions with co-localizing G3BP1 
(p = 0.001) (Fig. 5b). The p value of comparing the single 
protein mutation, i.e., F380L/F382L G3BP1 mutation or 
W32S SOD1 mutation, to the combined mutations in both 
proteins is also 0.001. The p values for the above pair-wise 
comparisons were determined by ANOVA with post hoc 
Tukey HSD test. The results suggest that, disruption of the 
mutant SOD1–G3BP1 interaction by substituting the criti-
cal residues (W32 in SOD1 and F380 and F382 in G3BP1) 
significantly reduced the double-positive inclusions.
Mutant SOD1 interferes with the dynamics of induced 
G3BP1 stress granules
We hypothesized that the interaction of mutant SOD1 
with G3BP1 could perturb the G3BP1-mediated stress 
granule dynamics. We tested this hypothesis by examin-
ing the formation of induced G3BP1 stress granules in 
N2A cells transfected with WT or A4V mutant SOD1 
upon exposure to hyperosmolar stress (Fig. 6b) or arsen-
ite treatment (Fig. 6c). The cells were treated with 0.5 M 
sorbitol or 0.5 mM arsenite dissolved in fresh medium for 
Fig. 5  The effect of W32 residue in SOD1 and F380 and F382 resi-
dues in G3BP1 on co-inclusions. a Confocal microscopic images 
of G3BP1-null 293T cells transfected with combinations of EGFP-
tagged A4V or A4V/W32S SOD1 and mCherry-tagged WT or 
F380L/F382L mutant G3BP1. B More than 150 cells in 10 random 
view-fields were quantified as with green, red and green/red co-local-
ized inclusions. The percentage of cells with green/red co-inclusions 
versus the total number of cells with green inclusions was calculated. 
The results of three independent parallel experiments are shown. 
Mutations of W32, F380 and F382 residues in individual or both 
proteins reduced the co-inclusions of mutant SOD1 and G3BP1. *p 
values less than 0.01 as determined by ANOVA with post hoc Tukey 
HSD test
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Fig. 6  Mutant SOD1 expres-
sion interferes with the induc-
tion of G3BP1 stress granules 
upon hyperosmolar stress or 
arsenite treatment. Confocal 
microscopic images of N2A 
cells expressing EGFP-tagged 
WT or A4V SOD1 (green) 
without treatment (a), or 30 min 
of sorbitol-induced hyperos-
molar stress (b), or 30 min 
of arsenite treatment (c). The 
endogenous G3BP1 (purple) 
and TIA1 (red) were stained 
and images were acquired 
with a Nikon A1 microscope. 
The nuclei were stained with 
DAPI. Scale bars 10 μm. d 
Time course of the number of 
G3BP1 granules upon sorbitol-
induced hyperosmolar stress, 
with or without recovery in 
fresh medium. e Time course of 
the number of G3BP1 granules 
upon arsenite treatment, with 
or without recovery in fresh 
medium. f Quantification of 
the number of G3BP1 granules 
in N2A cells transfected with 
EGFP vector or EGFP-tagged 
WT or A4V SOD1. A half or a 
quarter amount of A4V plasmid 
was used to examine how A4V 
mutant SOD1 levels influenced 
the number of G3BP1-positive 
granules. *p  < 0.05 and 
**p  < 0.01 as determined by 
ANOVA with post hoc Tukey 
HSD test. The quantification 
was based on four parallel 
experiments, representing over 
250 randomly selected cells for 
each cell population
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30 or 60 min, or allowed to recover for 30 or 60 min in 
fresh medium after 60 min of stress. Control cells were 
subjected to the same procedure with medium not contain-
ing sorbitol or arsenite (Fig. 6a). The cellular distributions 
of SOD1-EGFP, G3BP1 (purple) and an additional stress 
granule marker TIA1 (red) were determined by immuno-
fluorescence (Fig. 6a–c). It is noted that nearly all G3BP1 
granules were also positive of TIA1.
The number of G3BP1 granules per cell was quanti-
fied from ten random view-fields for each cell population 
at each time point. We found that after 30 min of hyperos-
molar stress, the average number of G3BP1 granules was 
significantly less in cells expressing A4V mutant SOD1 as 
compared to cells expressing WT SOD1 (p = 0.005, Stu-
dent’s t test) (Fig. 6d), suggesting a delayed formation of 
stress granules in response to hyperosmolar stress. Simi-
larly, the average number of G3BP1 granules was signifi-
cantly less in cells expressing A4V mutant SOD1 as com-
pared to cells expressing WT SOD1 (p = 0.01, Student’s t 
test) (Fig. 6e) 30 min after arsenite treatment. The results 
consistently suggest that mutant SOD1 delayed the forma-
tion of stress granules.
We further tested the effect of different levels of A4V 
expression on the formation of G3BP1-positive stress gran-
ules (Fig. 6f). N2A cells were transfected with EGFP vec-
tor control or EGFP-tagged WT, A4V, or only half or quar-
ter of A4V plasmids. The total amount of plasmids used in 
all experiments was constant by including EGFP vector as 
make-up. There was no statistically significant difference 
in the number of G3BP1 granules in cells transfected with 
the EGFP vector control or WT SOD1, suggesting that the 
EGFP tag did not interfere with the experiment. Transfec-
tion of the full or half amount of A4V SOD1 resulted in 
statistically significant reduction of the number of G3BP1 
granules as compared to WT SOD1 transfection (p = 0.001 
and 0.03, respectively, ANOVA with post hoc Tukey HSD 
test), whereas transfecting only the quarter amount of 
A4V SOD1 did not result in statistically different num-
ber of G3BP1 granules. Accordingly, our results support 
the hypothesis that mutant SOD1 affects the dynamics of 
G3BP1-positive stress granules, specifically delayed the 
formation of stress granules.
Discussion
SOD1 was the first gene whose mutations were identified 
to cause familial ALS [14, 51]. The cytoplasmic SOD1-
positive protein inclusions in affected motor neurons are a 
hallmark of mutant SOD1-mediated ALS [50, 68]. In other 
ALS cases, the pathological inclusions are often immune-
positive of the RNA-binding protein TDP-43 [41, 60]. In 
recent years, alterations in the dynamics of stress granules 
have emerged as a common theme in a wide range of ALS 
cases [18, 36, 72]. ALS-related mutations in a range of 
genes including TDP-43, FUS, hnRNPA1, profilin-1, angi-
ogenin and C9ORF72 were found to result in abnormali-
ties in stress granule dynamics [2, 4, 7, 13, 20, 22, 33, 38, 
59, 61, 63, 69]. Ataxin-2, an ALS risk factor with polyglu-
tamine expansions, can also regulate stress granules [19, 
46]. These observations suggest that mutant SOD1-medi-
ated ALS might represent an outlier in the ALS disease 
mechanism. At the same time, the nature of the gain-of-
toxicity caused by mutant SOD1 [9] is still not fully under-
stood. This study was initiated to determine whether mutant 
SOD1 also causes perturbed stress granule dynamics.
We have demonstrated here that cytoplasmic inclusions 
of mutant SOD1 were immune-positive for two reliable 
stress granule markers G3BP1 [31, 32] and TIA1 in the 
G93A mutant SOD1 transgenic mouse spinal cord (Fig. 1a, 
Supplemental Fig. 1), fibroblast cells derived from human 
ALS patient (Fig. 1c, Supplemental Fig. 3), and cultured 
cells (Fig. 1d, Supplemental Figs. 4, 5). A third stress gran-
ule marker eIF3 was also co-localized with mutant SOD1 
and G3BP1 in cultured N2A cells (Supplemental Fig. 4). 
Moreover, the G3BP1-positive mutant SOD1 inclusions 
were found closely juxtaposed to P-bodies (Fig. 1f), sup-
porting that they constitute stress granules [32]. It was pre-
viously reported that RNA stabilizer Hu Antigen R (HuR) 
and TIA1-related protein (TIAR) were found along with 
mutant SOD1 in detergent-insoluble aggregates [39]. How-
ever, that study did not test whether mutant SOD1 was 
co-localized in stress granules. Our results provide the evi-
dence that mutant SOD1 is co-localized with stress gran-
ules and consequently can potentially influence the dynam-
ics of stress granules.
We found that the molecular basis for the co-localization 
of mutant SOD1 inclusions and G3BP1 is that multiple 
mutants of SOD1, but not WT SOD1, interact with G3BP1 
(Fig. 2). This interaction was independent of RNA (Fig. 2c) 
and was reconstituted with purified mutant SOD1 and 
G3BP1 proteins (Fig. 2d), showing that mutant SOD1 and 
G3BP1 directly interact with each other. In the previous 
study showing the presence of HuR and TIAR in mutant 
SOD1 aggregates, the amount of HuR and TIAR was sig-
nificantly reduced by RNase treatment [39], suggesting 
an indirect interaction between mutant SOD1 and HuR/
TIAR. This is in contrast to the RNA-independent direct 
interaction between mutant SOD1 and G3BP1 found in this 
study. Moreover, the interaction appeared to be specific for 
G3BP1, while four other RNA-binding proteins implicated 
in ALS, hnRNPA1, FUS, TDP-43 or Matrin-3 did not inter-
act with mutant SOD1 (Fig. 3).
We further demonstrated that the RRM domain of 
G3BP1 is essential and sufficient for the interaction with 
mutant SOD1 (Fig. 4b, c). Molecular modeling and in silico 
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docking results suggest that the F380 and F382 residues of 
G3BP1 and the W32 residue of mutant SOD1 play a role in 
this interaction (Fig. 4d). Site-directed mutagenesis results 
showed that mutating F380 and F382 in G3BP1 and W32 
in SOD1 indeed impaired the interaction (Fig. 4e). The 
W32 residue of human SOD1 resides in the middle of the 
third β-strand [25] and is exposed on the protein surface, 
thus it is reasonable that it is involved in the interaction 
with G3BP1. It has been reported that W32 potentiated the 
aggregation and cytotoxicity of ALS mutant SOD1 [62]. In 
addition, other ALS-related mutants of SOD1 were reported 
to display aberrantly increased hydrophobicity [64], which 
can enable the interaction with G3BP1. Consistent with 
the interaction results, the W32S SOD1 mutation and the 
F380L/F382L G3BP1 mutation significantly impaired the 
co-localization of A4V SOD1 with G3BP1 (Fig. 5).
We found that expression of mutant SOD1 delayed the 
formation of G3BP1 stress granules in response to hyper-
osmolar stress and arsenite treatment (Fig. 6). Hyperos-
molar stress was chosen in our study since it was shown to 
induce FUS [53] and TDP-43 [15] stress granules. Arsen-
ite treatment is widely used to induce stress granules as it 
induced oxidative stress [56]. There are multiple potential 
mechanisms how the ALS mutant SOD1–G3BP1 interac-
tion could perturb stress granule dynamics. The F380 and 
F382 residues are well conserved in the “3” and “5” posi-
tions of the RNP1 motif (Supplemental Fig. 6A), which 
are critical to RNA binding [42]. Substitution of conserved 
phenylalanine residues in the RNP1 motif were reported 
to impair RNA binding [8, 11, 54]. It is noted that F380L/
F382L mutation significantly reduced the interaction 
between G3BP1 and PABP1 (Fig. 4e, lanes 6 and 8). Simi-
larly, the G3BP1-PABP1 interaction was abolished in the 
presence of RNase (Fig. 2c, lane 6), suggesting that F380L/
F382L mutation impaired the RNA binding of G3BP1. 
Furthermore, we performed the RNA immunoprecipitation 
experiment to measure the amount of c-myc RNA (one of 
the few known RNA-binding partners of G3BP1 [66]) co-
precipitated with G3BP1. The F380L/F382L double mutant 
G3BP1 co-precipitated significantly less endogenous 
c-myc mRNA than WT G3BP1 (p = 2.7 × 10−4), con-
firming that the F380 and F382 residues are important for 
G3BP1 RNA binding (Supplemental Fig. 6b). As discussed 
earlier, the interaction between mutant SOD1 and G3BP1 
is not mediated by RNA, but rather direct protein–protein 
interaction (Figs. 2, 4). It is conceivable that, when F380 
and F382 are engaged in the interaction with mutant SOD1, 
the RNA-binding ability of G3BP1 is impaired (a “compet-
itive binding” model). Since G3BP1 plays a critical role in 
stress granule dynamics [2, 65, 70], its impaired RNA bind-
ing can result in the delayed formation of stress granules.
An alternative mechanism is that mutant SOD1 can 
sequester G3BP1 into inclusions, thus interfering with the 
G3BP1-mediated stress granule formation and dynamics. It 
is interesting to note “rimming” of mutant SOD1 inclusions 
by G3BP1 in cultured cells (Supplemental Fig. 5). Rim-
ming of pathological aggregate structures was reported in 
other neurodegenerative diseases, e.g., the rimming of hun-
tingtin aggregates by p62 [6] or HDAC6 [28]. This observa-
tion suggests that G3BP1 could be secondarily sequestered 
to mutant SOD1 inclusions, thus contributing to impaired 
stress granule dynamics (a “sequestration” model). Future 
studies are needed to distinguish these two potential mech-
anisms. It is also noted that G3BP1-positive granules were 
relatively small in cells under hyperosmolar stress (Fig. 6b) 
and large in cells treated with arsenite (Fig. 6c). In addi-
tion to the number of granules in this study, future studies 
using live cell imaging techniques will examine sizes of 
individual granules and determine whether multiple smaller 
granules merge into large granules under different stress 
conditions.
A delayed formation of stress granules in the presence 
of mutant SOD1 (Fig. 6) are reminiscent of the reports 
that the expression of ALS mutants of TDP-43 and FUS 
also resulted in altered stress granules [4, 15, 38]. These 
findings suggest that the misregulation of stress granule 
dynamics represents a common pathophysiological feature 
shared by ALS cases mediated by mutant SOD1 and those 
caused by mutations in proteins involved in RNA metabo-
lism. Perturbation of the physiological function of G3BP1 
is especially harmful to neurons since G3BP1 is a neuronal 
survival factor [43, 73]. The full complement of RNAs reg-
ulated by G3BP1 and in general by stress granules in the 
central nervous system is unknown. In addition, it remains 
unclear whether RNA molecules reside in the mutant SOD1 
and G3BP1 positive co-inclusions or what functional role 
RNAs play in the inclusions. Future studies will determine 
the range of RNAs whose stability and function is affected 
by altered stress granule dynamics in ALS.
Taken together, our results suggest that the aberrant 
interaction of ALS-related SOD1 mutants with G3BP1 and 
the resulting perturbation of stress granule dynamics are 
likely important components of the toxicity of SOD1 muta-
tions. In addition, a number of stress conditions are known 
to induce G3BP1-positive stress granules that might in turn 
seed mutant SOD1 inclusions. This two-hit scenario might 
enhance the pathological aggregation of mutant SOD1. Our 
findings reconcile the seemingly disparate disease mecha-
nisms caused by mutations in SOD1 and several other 
genes involved in RNA metabolism.
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